Search
2023 Moving towards a rabies-free Southeast Asia_Whitepaper.pdf
pipeline-october-2023
DYNAGITO Infographic
Guide to Partnering with AH
Manifesto-Infographics
Respiratory Research and Development Timeline.pdf
Praxbind® – the specific reversal agent to dabigatran.pdf
Candice is moving to Germany
Are you considering a career at Boehringer Ingelheim? Find out why Candice loves working here. For more talent insights, visit our Careers Page.
Vikas joined from hospital sector
Are you considering moving into pharmaceuticals for the first time? Vikas made the leap and has never looked back.
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
BI 764198: TRPC6 inhibitor
BI 764198: TRPC6 inhibitor
TRPC6 inhibitor
PDE4B inhibitor
GlyT1 inhibitor
CatC inhibitor
Oxidase Inhibitor
Aldosterone synthase inhibitor
Ion channel inhibitor
Ion channel inhibitor
KRAS multi-inhibitor
KRAS multi-inhibitor
Oxidase Inhibitor
Oxidase Inhibitor
SGLT2 inhibitor
BI 765845: Heart disease modulator | Myocardial infarction
BI 765845: Heart disease modulator | Myocardial infarction
BI 1291583: CatC Inhibitor
BI 1291583: CatC Inhibitor